Current News

Print version | PDF version | Send article | RSS-Feed

Gambro BCT purchases UK sterile solutions manufacturer

30 Apr 2004 - Gambro announced that its wholly owned subsidiary, Gambro BCT, Inc., is intending to acquire the assets of Ivex Pharmaceuticals Limited (Ivex), a subsidiary of Galen Holdings plc. Ivex develops and manufactures sterile solutions for the pharmaceutical and medical device industry, in its US Food and Drug Administration approved manufacturing facility.
 
Ivex is expected to be incorporated into the Gambro BCT business as of May 2004 and the consideration will be approximately GBP 2.5M plus inventories.
 
Ivex, in business for 25 years, has manufactured ACD-A anticoagulant and AS-3 red cell storage solution for Gambro BCT for four years. ACD-A is used for anticoagulation of blood collected on the TrimaŽ Automated Blood Collection and the Spectra(TM) Apheresis Systems. AS-3 solution is used to store red blood cells collected using the Trima and other automated collection systems. This acquisition will ensure that Gambro BCT can provide these important solutions to blood banks, increase the company's revenue, as well as directly gain further core capabilities in the development and manufacturing of sterile solutions. The superior R&D and Operations capabilities of Ivex will also support Gambro BCT's future solution needs for automated whole blood processing and pathogen reduction technology in blood banks.
 
Ivex Pharmaceutical's sales for 2003 were GBP 7.6M. Revenue consists largely of contract sterile solutions manufacturing, with the remainder of its business comprising manufacturing hospital and veterinary solutions for UK customers. Ivex is located in Larne, Northern Ireland and has approximately 100 employees.